Skip to main content
SpringerLink
Log in

Glomerular disease

ACEIs with or without corticosteroids in IgA nephropathy?

  • News & Views
  • Published:

From Nature Reviews Nephrology

View current issue Sign up to alerts

A recent study demonstrated the superiority of prednisone plus ramipril in preventing progression of IgA nephropathy compared with ramipril alone in a group of patients at high risk of progressive renal damage. However, future clinical trials need to clarify whether more aggressive supportive therapy may match the benefits of immunosuppression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Manno, C., Torres, D. D., Rossini, M., Pesce, F. & Schena, F. P. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy. Nephrol. Dial. Transplant. 24, 3694–3701 (2009).

    Article  CAS  Google Scholar 

  2. Lv, J. et al. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial. Am. J. Kidney Dis. 53, 26–32 (2009).

    Article  CAS  Google Scholar 

  3. Floege, J. & Eitner, F. Immune modulating therapy for IgA nephropathy: rationale and evidence. Semin. Nephrol. 28, 38–47 (2008).

    Article  CAS  Google Scholar 

  4. Pozzi, C. et al. Corticosteroids in IgA nephropathy: a randomised controlled trial. Lancet 353, 883–887 (1999).

    Article  CAS  Google Scholar 

  5. Praga, M., Gutiérrez, E., González, E., Morales, E. & Hernández, E. Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial. J. Am. Soc. Nephrol. 14, 1578–1583 (2003).

    Article  CAS  Google Scholar 

  6. Reich, H. N., Troyanov, S., Scholey, J. W. & Cattran, D. C. Remission of proteinuria improves prognosis in IgA nephropathy. J. Am. Soc. Nephrol. 18, 3177–3183 (2007).

    Article  CAS  Google Scholar 

  7. Eitner, F., Ackermann, D., Hilgers, R. D. & Floege, J. Supportive Versus Immunosuppressive Therapy of Progressive IgA nephropathy (STOP) IgAN trial: rationale and study protocol. J. Nephrol. 21, 284–289 (2008).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology and Immunology, RWTH University of Aachen, Pauwelsstrasse 30, Aachen, 52057, Germany

    Frank Eitner & Jürgen Floege

Authors
  1. Frank Eitner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jürgen Floege
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jürgen Floege.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eitner, F., Floege, J. ACEIs with or without corticosteroids in IgA nephropathy?. Nat Rev Nephrol 6, 252–254 (2010). https://doi.org/10.1038/nrneph.2010.31

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2010.31

  • Springer Nature Limited

This article is cited by

Search

Navigation